The online edition of Proceedings of the National Academy of Sciences reports that Cincinnati University (UC) researchers have discovered that apolipoprotein A-IV (apoA-IV), a naturally produced protein that has the ability to reduce blood sugar levels and enhance insulin secretion, could be a potential target for a new diabetes treatment. ApoA-IV is a protein secreted by the small intestine in response to fat absorption. According to earlier studies, apoA-IV is elevated in individuals following gastric bypass surgery, which is linked to improved symptoms in diabetes...
Realtime Related Tweets
meredith vieira prop 8 larry bird maria menounos proposition 8 ricky martin chauncey billups
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.